Table 1.
miRNA | Stimulus | Alteration | Transcription factors/ other cofactors |
Cell lines | Reference |
---|---|---|---|---|---|
miR-146a | LPS; TNF-α; IL-1β; LMP1; H2O2 |
Up | P65 | Human monocytic cell; human neural cells; human alveolar epithelial A cells; human monocyte-derived dendritic cells; human PMN and monocytes |
25, 27, 30, 31, 92 |
miR-21 | LPS; C. parvum; nicotine |
Up | P65; P50 | Human biliary epithelial cells; gastric cancer cells; human peripheral blood mononuclear cells |
32, 34, 35, 85 |
miR-23b | LPS; C. parvum | Up | P65 | Human biliary epithelial cells | 34, 35 |
miR-27b | LPS; C. parvum | Up | P65 | Human biliary epithelial cells; human macrophages | 26, 34, 35 |
miR-125ba | LPS; C. parvum | Up | P65 | Human biliary epithelial cells; human fibroblast-like synoviocytes; LPS-tolerized THP1 cells |
34, 35, 93, 94 |
Down | ND | Mouse Raw 264.7 macrophage; mouse primary macrophages; human monocyte-derived dendritic cells |
58, 83, 92 | ||
miR-30b | LPS; C. parvum | Up | P65 | Human biliary epithelial cells | 34, 35 |
miR-16 | Nicotine | Up | P65; P50 | Gastric cancer cells | 32 |
miR-301a | TNF-α | Up | P65; P50 | Pancreatic cancer cells | 33 |
miR-155 | LMP1; LPS; alcohol | Up | P65; P50 | Human B cells; mouse macrophage cells; mouse Kupffer cells; human PMN and monocytes |
27–29 |
miR-9 | LPS; TNF-α; IL-1β | Up | ND | Human PMN and monocytes, macrophages | 27 |
miR-29b | TNF-α | Down | P65; YY1; SP1; HDAC3; HDAC1 |
Human myoblast cell; human acute myeloid leukemia cells | 37, 38 |
let-7i | LPS; C. parvum | Down | P50; C/EBP-β; HDAC3 | Human biliary epithelial cells | 36 |
Abbreviations: C/EBP-β, CCAAT/enhancer-binding protein beta; C. parvum, Cryptosporidium parvum; HDAC1, histone deacetylase 1;HDAC3, histone deacetylase3;LMP1, Epstein–Barr virus-encoded latent membrane protein-1; LPS, lipopolysaccharide; ND, not determined; PMN, polymorphonuclear neutrophil; SP1, specificity protein 1; TNF-α, tumor necrosis factor-α; YY1, Yin Yang 1.
The expression of miR-125 after TLR activation is still controversial now.